1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Guidant Acquires CardioThoracic Systems

M&A Deal Summary

Guidant Acquires CardioThoracic Systems

On August 30, 1999, Guidant acquired medical products company CardioThoracic Systems for 313M USD

Acquisition Highlights
  • This is Guidant’s 1st transaction in the Medical Products sector.
  • This is Guidant’s largest (disclosed) transaction.
  • This is Guidant’s 2nd transaction in the United States.
  • This is Guidant’s 1st transaction in California.

M&A Deal Summary
Date 1999-08-30
Target CardioThoracic Systems
Sector Medical Products
Buyer(s) Guidant
Deal Type Add-on Acquisition
Deal Value 313M USD
Advisor(s) Navidar Holdco (Financial)

Target

CardioThoracic Systems

Cupertino, California, United States
CardioThoracic Systems, Inc. is a developer of proprietary technologies for use in less invasive cardiac surgery.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Guidant

Indianapolis, Indiana, United States
Category Company
Founded 1994
Sector Life Science
DESCRIPTION

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.

DEAL STATS #
Overall 2 of 4
Sector: Medical Products M&A 1 of 3
Type: Add-on Acquisition M&A Deals 2 of 4
State: California M&A 1 of 2
Country: United States M&A 2 of 3
Year: 1999 M&A 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1998-08-12 InControl

Redmond, Washington, United States

Incontrol, Inc. designs devices for the treatment of atrial arrhythmia, a common heart-rhythm disorder.

Buy $135M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-03 Everolimus Eluting/Biosensors International/

Singapore, Singapore

Biosensors International, a healthcare equipment company based in Singapore developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures.

Buy -
Mergr

Solution for

Product

Company

Legal